Maze Therapeutics, Inc. · NASDAQ:MAZE

James N. Topper reported a 10.20% stake in Maze Therapeutics, Inc. (Schedule 13G/A)

Event Apr 25, 2025 · Filed Apr 29, 2025

James N. Topper reported a 10.20% stake in Maze Therapeutics, Inc., 4,451,339 shares, as a passive investor on Apr 25, 2025. Filed Apr 29, 2025 (Schedule 13G/A).

Stake: 10.20%
Shares: 4,451,339
Intent: Passive
What changed: Stake changed
Filed together: 17 holders

The filing in full

Holder	Stake	Shares
Frazier Life Sciences Public Fund, L.P.	7.50%	3,272,062
FHMLSP, L.P.	7.50%	3,272,062
FHMLSP, L.L.C.	7.50%	3,272,062
Frazier Life Sciences Public Overage Fund, L.P.	2.20%	965,503
FHMLSP Overage, L.P.	2.20%	965,503
FHMLSP Overage, L.L.C.	2.20%	965,503
Frazier Life Sciences X, L.P.	0.20%	73,872
FHMLS X, L.P.	0.20%	73,872
FHMLS X, L.L.C.	0.20%	73,872
Frazier Life Sciences XI, L.P.	0.30%	139,902
FHMLS XI, L.P.	0.30%	139,902
FHMLS XI, L.L.C.	0.30%	139,902
James N. Topper	10.20%	4,451,339
Patrick J. Heron	10.20%	4,451,339
Albert Cha	9.70%	4,237,565
James Brush	9.70%	4,237,565
Daniel Estes	0.30%	139,902

Source

View original at SEC

Related